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INTRODUCTION AND AIMS POPULATION AND METHODS
Orthotopic liver transplantation (OLT) has become the treatment of choice for
advanced liver disease of almost any cause.
Improved outcomes among solid organ transplant recipients have
contributed to the growth in the absolute number of patients with chronic
kidney disease (CKD) in this group, and this complication significantly
compromises patients outcome1-3.
The aim of this study was to determine the incidence of acute and chronic
This was a retrospective study of 626 patients receiving 708 OLT,
transplanted in our unit between September 1992 and March 2007.
Clinical data: age at transplantation, gender, weight, aetiology for hepatic
failure, presence of diabetes mellitus, hypertension, hepatitis B and C
infection, renal dysfunction pre transplant (RD pre), immunosuppression
(ISS) and necessity for acute renal replacement therapy (RRT).
Laboratorial data: serum creatinine (Scr) values and/or glomerular filtration
renal disease, possible risk factors and the impact on the patient survival. rate (GFR), determined by Cockcroft-Gault equation, at the last observation
pre transplantation and at days 1, 7 and 21, month 6 and every year post
transplantation.
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RESULTS
708 OLT recipients:
• Male gender 64%
• Mean age: 44±12.6 years
Indications for transplantation
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• Diabetes in 106 patients (17%); Hypertension in 117 patients (18.8%)
• Mean follow up time 3.6 years, 29% > to 5 years
• Mean transplant survival: 75% at 12 months and 69% at 3 years
• RD pre (GFRe < 60 ml/min or Scr >1.5 mg/dl): 133 recipients (21.6%)
• Retransplanted: 82 recipients
• Death: 152 recipients
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AKI n=213 (33 8%) .
RRT in 15.5% (n=34)
Death in 30.5% (n=65)
CI 95% p R2
CKD stage 3 0.54 to 0.85 0.001
0.47
CKD stage 5d 0.03 to 0.3 0.02
Re transplantation 0.003 to 0.17 0.04
Mortality 0.01 to 0.17 0.02
GFRe ≤ 30% of pre transplant GFR
Scr ≥ 1.8 mg/dl
Renal recovery in 1.4% (n=3)
Linear Regression
    
n=355 (50.2%)
r p
Age 0.19 <0.001
Diabetes 0.88 0.003
Alcoholic Cirrhosis 0.09 0.015
Spearman Correlation
CI 95% p R2
Age 1.02 to 1.06 <0.001
RD pre 0.24 to 0.66 <0.001
Linear Regression
CKD
RD pre 0.28 <0.0001
AKI post transplant 0.32 <0.0001
Mortality 0.19 <0.0001
0.19AKI post transplant 0.37 to 0.95 0.03
Mortality 0.26 to 0.88 0.015
CI 95% P R2
RD pre 0.01 to 0.14 0.02
0.18AKI post transplant 0.06 to 0.26 <0.001
CKD stage 5d 0 34 to 0 61 <0 001
MORTALITY
Linear Regression
CONCLUSIONS
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OLT are disposed to acute and chronic  renal complications that have negative impact in the survival of these patients.
Renal dysfunction seems to be more important than the need of re transplant in what concerns clinical prognostic.
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